Similar Search Results

Pharmaceutical markets in Japan and the United States

Comanor, William S. - In: International journal of economic policy studies 16 (2022) 2, pp. 355-370

Persistent link: https://www.econbiz.de/10013433326

Determinants of drug prices and expenditures

Comanor, William S.; Schweitzer, Stuart O. - In: Managerial and decision economics : MDE ; the … 28 (2007) 4/5, pp. 357-370

Persistent link: https://www.econbiz.de/10003543678

Value based pricing of pharmaceuticals in the US and UK : does centralized cost effectiveness analysis matter?

Comanor, William S.; Schweitzer, Stuart O.; Riddle, Jon M. - In: Review of industrial organization : RIO 52 (2018) 4, pp. 589-602

Persistent link: https://www.econbiz.de/10012008043

Costs and benefits of branded drugs : insights from cost-effectiveness research

Frech, Henry Edward; Pauly, Mark V.; Comanor, William S.; … - In: Journal of benefit-cost analysis : JBCA 13 (2022) 2, pp. 166-181

The relationship between costs and health benefits of branded pharmaceuticals remains controversial. This paper examines the incremental costs incurred for incremental health benefits gained from the largest available sample of cost-effectiveness studies of branded drugs in the USA, the...

Persistent link: https://www.econbiz.de/10013366987